# Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

> **NCT06891872** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Sinovac (Dalian) Vaccine Technology Co., Ltd.** · enrollment: 720 (estimated)

## Conditions studied

- Varicella (chickenpox)
- MMR Vaccine
- DTaP Vaccine

## Interventions

- **BIOLOGICAL:** Vaicella Vaccine+DTaP on Day 0, MMR on Day 30
- **BIOLOGICAL:** Varicella vaccine+MMR on Day 0，DTaP on Day 30
- **BIOLOGICAL:** Varicella Vaccine

## Key facts

- **NCT ID:** NCT06891872
- **Lead sponsor:** Sinovac (Dalian) Vaccine Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 720 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06891872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06891872, "Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06891872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*